bronchoalveolar
lavag
bal
major
diagnost
tool
lung
diseas
includ
viral
respiratori
infect
aim
better
defin
situat
viral
test
perform
bal
fluid
balf
retrospect
studi
case
viral
test
immunofluoresc
immunocytochemistri
viral
cultur
andor
polymeras
chain
reaction
pcr
perform
balf
period
year
institut
compar
characterist
patient
virusposit
versu
virusneg
balf
balf
sampl
sent
microbiolog
laboratori
underw
viral
test
posit
identifi
virus
herp
simplex
viru
hsv
cytomegaloviru
cmv
epsteinbarr
viru
ebv
human
herpesviru
hhv
respiratori
syncyti
viru
rsv
rhinoviru
adenoviru
variabl
associ
posit
viral
test
univari
analysi
immunosuppress
human
immunodefici
viru
hiv
corticosteroid
mgday
week
immunosuppress
therapi
groundglass
attenu
comput
tomographi
ct
scan
lateonset
ventilatorassoci
pneumonia
vap
durat
hospit
stay
ii
intens
care
unit
icu
stay
iii
mechan
ventil
bal
p
comparison
multivari
analysi
immunosuppress
odd
ratio
confid
interv
ci
p
groundglass
attenu
remain
associ
virusposit
bal
none
viral
test
perform
balf
initi
assess
diffus
infiltr
lung
diseas
posit
pcr
improv
diagnost
yield
viral
test
balf
test
virus
balf
mostli
restrict
immunocompromis
patient
acut
respiratori
diseas
andor
patient
unexplain
groundglass
attenu
ct
scan
bronchoalveolar
lavag
bal
major
diagnost
tool
infecti
lung
diseas
especi
immunocompromis
patient
viral
agent
play
import
role
etiolog
pneumonia
immunocompet
immunocompromis
host
may
involv
substanti
proport
asthma
chronic
obstruct
pulmonari
diseas
copd
exacerb
develop
molecular
biolog
techniqu
includ
polymeras
chain
reaction
pcr
dramat
increas
yield
viral
test
variou
respiratori
diseas
howev
studi
perform
specif
set
highli
select
patient
henc
yield
viral
test
bal
fluid
balf
remain
poorli
character
routin
practic
key
dilemma
develop
new
test
rel
high
cost
associ
nondiscrimin
use
better
inform
use
viral
test
patient
respiratori
diseas
perform
observ
retrospect
studi
institut
three
aim
assess
diagnost
valu
viral
test
balf
routin
practic
ii
analyz
characterist
patient
virusposit
balf
iii
identifi
factor
predict
posit
viral
test
balf
pontchail
univers
hospit
tertiarycar
hospit
serv
referr
center
area
renn
franc
adult
year
age
viral
test
perform
balf
year
includ
case
identifi
computer
databas
virolog
depart
data
extract
databas
medic
record
use
standard
questionnair
protocol
approv
institut
review
board
renn
univers
hospit
ethic
committe
project
approv
number
inform
consent
waiv
data
collect
includ
demograph
inform
comorbid
alcohol
abus
defin
daili
consumpt
unitsday
men
unitsday
women
patient
classifi
immunocompromis
infect
human
immunodefici
viru
hiv
system
corticosteroid
mgday
least
week
immunosuppress
drug
admiss
medic
chart
check
follow
sign
fever
cough
purul
sputum
hemoptysi
chest
pain
dyspnea
crackl
chest
examin
radiograph
pattern
prior
bal
defin
type
consolid
alveolar
interstiti
nodul
micronodul
groundglass
attenu
bronchiectasi
excav
data
collect
includ
antimicrobi
treatment
receiv
week
preced
bal
mechan
ventil
intens
care
unit
icu
admiss
inhospit
mortal
bal
perform
accord
guidelin
local
anesthet
lidocain
spray
ml
steril
salin
solut
instil
time
distal
bronchial
tree
either
site
radiograph
abnorm
predomin
middl
lobe
case
diffus
radiograph
pattern
balf
specimen
aliquot
immedi
transport
laboratori
appropri
stain
carri
direct
identif
bacteria
mycobacteria
fungi
parasit
cultur
bacteri
identif
inocul
standard
aerob
condit
four
differ
media
well
specif
media
mycobacterium
spp
indic
usual
respiratori
pathogen
bacteri
count
consid
signific
quantit
cultur
yield
cfuml
specimen
addit
test
atyp
pneumonia
agent
perform
request
physician
charg
balf
ie
pcr
immunofluoresc
specif
stain
cultur
appropri
media
serolog
first
sampl
balf
use
viral
test
like
contain
signific
number
epitheli
cell
sampl
mix
volum
viral
transport
medium
ie
minimum
essenti
medium
enrich
sorbitol
bovin
serum
albumin
streptomycin
vancomycin
colimycin
amphotericin
b
balf
first
analyz
immunofluoresc
panel
monoclon
antibodi
respiratori
syncyti
viru
rsv
b
influenza
virus
parainfluenza
virus
adenoviru
well
herp
simplex
virus
hsv
immunocompromis
patient
parallel
balf
inocul
onto
monolay
cell
also
onto
mdck
cell
influenza
season
immunocompromis
patient
immunocytochemistri
icc
cytomegaloviru
cmv
perform
detect
viral
genom
carri
accord
clinic
context
request
physician
charg
cmv
varicella
zoster
viru
vzv
epsteinbarr
viru
ebv
human
herpesviru
hhv
detect
use
commerci
method
herp
franc
addit
cmv
ebv
influenza
b
detect
inhous
pcr
adapt
previous
describ
method
neither
pcr
test
nasopharyng
swabaspir
viral
serolog
test
routin
perform
studi
period
institut
statist
analys
perform
use
sa
softwar
sa
institut
inc
cari
nc
usa
result
present
mean
standard
deviat
rang
parenthes
compar
characterist
patient
virusposit
versu
virusneg
balf
use
student
ttest
mannwhitney
test
n
quantit
variabl
fisher
exact
test
categor
variabl
multipl
comparison
perform
use
analysi
varianc
bonferroni
post
hoc
correct
multivari
analysi
perform
use
logist
regress
model
adjust
durat
stay
balf
variabl
pvalu
univari
analysi
enter
multivari
analysi
valu
p
regard
signific
balf
sampl
sent
microbiolog
depart
institut
viral
test
order
balf
patient
fig
mean
age
patient
year
rang
maletofemal
ratio
symptom
admiss
includ
dyspnea
cough
fever
mean
bodi
temperatur
rang
purul
sputum
hemoptysi
chest
radiograph
find
includ
consolid
nodul
excav
chest
comput
tomographi
ct
scan
perform
patient
indic
groundglass
attenu
micronodul
bronchiectasi
procedur
bal
perform
icu
includ
procedur
perform
mechan
ventil
mean
volum
steril
salin
serum
instil
bal
procedur
ml
rang
use
viral
transport
medium
adequ
sampl
bal
investig
virus
identifi
least
one
viru
total
virus
mean
virus
per
virusposit
balf
viral
speci
identifi
yield
four
techniqu
use
detail
tabl
note
virus
member
herpesvirida
famili
frequent
viru
associ
cmv
ebv
one
hivinfect
patient
interstiti
pneumonia
three
herp
virus
identifi
bal
cmv
icc
viral
cultur
ebv
pcr
pcr
perform
balf
posit
case
pcr
test
posit
viru
case
confirm
diagnosi
document
techniqu
case
cmv
ebv
cmv
identifi
viru
differ
document
techniqu
eight
case
pcr
use
diagnost
yield
would
henc
pcr
improv
diagnost
yield
viral
test
balf
test
bacteria
mycobacteria
perform
balf
posit
balf
comparison
virusposit
virusneg
balf
detail
tabl
univari
analysi
variabl
significantli
associ
posit
viral
test
univari
analysi
immunosuppress
ie
hiv
infect
corticosteroid
mgday
week
andor
immunosuppress
therapi
groundglass
attenu
chest
ct
scan
lateonset
ventilatorassoci
pneumonia
vap
durat
hospit
stay
ii
icu
stay
iii
mechan
ventil
bal
perform
p
comparison
multivari
analysi
adjust
durat
stay
bal
immunosuppress
odd
ratio
confid
interv
ci
p
groundglass
attenu
ci
remain
significantli
associ
virusposit
bal
retrospect
analysi
medic
chart
allow
us
classifi
indic
viral
analysi
balf
eight
categori
tabl
estim
diagnost
yield
viral
test
subgroup
strike
differ
observ
exampl
proport
virusposit
balf
immunocompromis
patient
compar
immunocompet
patient
p
none
bal
perform
initi
assess
diffus
infiltr
lung
diseas
virusposit
associ
viral
analysi
bronchoalveolar
lavag
bal
outcom
receiv
antivir
agent
aciclovir
ganciclovir
valganciclovir
foscarnet
icu
patient
virusposit
balf
like
treat
nonicupati
virusposit
balf
vs
signific
associ
antivir
treatment
outcom
patient
virusposit
bal
observ
studi
evalu
diagnost
yield
viral
test
balf
request
physician
charg
consecut
balf
test
virus
posit
previou
studi
estim
diagnost
yield
viral
test
balf
differ
set
proport
virusposit
balf
rang
depend
popul
studi
eg
immunocompromis
icu
patient
viral
techniqu
use
eg
pcr
icc
cultur
broad
rang
respiratori
diseas
associ
viral
infect
henc
test
virus
balf
may
consid
patient
wide
spectrum
clinic
radiolog
abnorm
howev
studi
suggest
viral
test
unlik
return
posit
except
two
nonexclus
situat
immunocompromis
patient
ii
bilater
groundglass
attenu
ct
scan
studi
vast
major
virus
detect
belong
herpesvirida
famili
mainli
cmv
replic
observ
plasma
onethird
cmvseroposit
patient
vap
day
mechan
ventil
lung
involv
document
cmvrelat
cytopathogen
effect
patient
studi
found
hsv
cmv
balf
associ
increas
morbid
mortal
howev
causal
relationship
hsv
cmv
balf
patient
outcom
ascertain
observ
studi
among
rapid
test
current
avail
pcr
one
valuabl
result
avail
within
hour
high
sensit
especi
immunocompromis
patient
multiplex
pcr
test
abil
detect
sever
virus
one
set
may
particularli
interest
diagnost
workup
acut
respiratori
diseas
suspect
viral
origin
studi
diagnost
yield
viral
test
would
drop
pcr
test
perform
advoc
systemat
use
pcr
techniqu
viral
test
balf
accord
previou
studi
situat
virus
may
reason
suspect
ie
acut
lower
tract
respiratori
diseas
immunocompromis
patient
andor
patient
unexplain
bilater
groundglass
attenu
ct
scan
hand
initi
assess
immunocompet
patient
interstiti
lung
diseas
includ
viral
test
balf
previous
report
patient
interstiti
fibrosi
exacerb
idiopath
fibrosi
viral
test
balf
may
higher
valu
although
recent
paper
question
clinic
signific
studi
limit
relat
retrospect
monocentr
observ
design
investig
balf
protocol
request
viral
test
left
discret
physician
charg
firstli
retrospect
review
medic
chart
identifi
signific
proport
patient
unlik
suffer
viral
infect
viral
test
perform
contrast
among
patient
includ
studi
viral
test
request
probabl
patient
would
benefit
viral
test
balf
howev
comparison
patient
balf
test
virus
random
select
patient
balf
sampl
test
virus
year
found
signific
differ
immunodepress
vs
p
groundglass
attenu
ct
scan
vs
p
suggest
clinician
awar
situat
like
associ
presenc
virus
appropri
select
patient
viral
test
like
return
posit
lastli
pcr
perform
balf
investig
virus
systemat
use
pcr
test
patient
may
increas
proport
virus
identifi
secondli
identif
viru
balf
diagnost
workup
respiratori
diseas
systemat
impli
viru
respons
diseas
patient
improv
appropri
antivir
treatment
despit
limit
observ
studi
allow
us
identifi
categori
respiratori
diseas
viral
test
unlik
return
posit
eg
initi
assess
immunocompet
patient
interstiti
pneumonia
pulmonari
micronodul
consequ
indic
viral
test
balf
dramat
reduc
patient
institut
conclus
test
virus
balf
mostli
restrict
acut
lower
tract
respiratori
diseas
immunocompromis
patient
andor
patient
unexplain
groundglass
attenu
ct
scan
especi
pcr
test
use
acknowledg
author
thank
jeanmarc
malecot
statist
advic
author
declar
conflict
interest
ard
acut
respiratori
distress
syndrom
patient
classifi
immunocompromis
infect
human
immunodefici
viru
hiv
system
corticosteroid
mgday
least
week
immunosuppress
therapi
b
clinic
radiolog
deterior
immunocompet
patient
infiltr
lung
diseas
chronic
cough
postsurg
atelectasi
pulmonari
abscess
unexplain
hyperleukocytosi
mechan
ventil
initi
assess
pulmonari
nodul
system
granulomatosi
screen
bone
marrow
allograft
patient
illdefin
pulmonari
abnorm
